Annual CFO
-$15.76 M
+$3.10 M+16.45%
December 31, 2023
Summary
- As of March 6, 2025, INKT annual cash flow from operations is -$15.76 million, with the most recent change of +$3.10 million (+16.45%) on December 31, 2023.
- During the last 3 years, INKT annual CFO has fallen by -$7.42 million (-89.05%).
- INKT annual CFO is now -89.05% below its all-time high of -$8.34 million, reached on December 31, 2020.
Performance
INKT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$2.99 M
-$704.20 K-30.74%
September 30, 2024
Summary
- As of March 6, 2025, INKT quarterly cash flow from operations is -$2.99 million, with the most recent change of -$704.20 thousand (-30.74%) on September 30, 2024.
- Over the past year, INKT quarterly CFO has stayed the same.
- INKT quarterly CFO is now -75.93% below its all-time high of -$1.70 million, reached on December 31, 2021.
Performance
INKT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$10.86 M
+$1.21 M+10.05%
September 30, 2024
Summary
- As of March 6, 2025, INKT TTM cash flow from operations is -$10.86 million, with the most recent change of +$1.21 million (+10.05%) on September 30, 2024.
- Over the past year, INKT TTM CFO has stayed the same.
- INKT TTM CFO is now -158.12% below its all-time high of -$4.21 million, reached on March 31, 2021.
Performance
INKT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
INKT Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.4% | 0.0% | 0.0% |
| 3 y3 years | -89.0% | 0.0% | 0.0% |
| 5 y5 years | -5.5% | 0.0% | 0.0% |
INKT Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -22.9% | +16.4% | -75.9% | +46.7% | at high | +42.9% |
| 5 y | 5-year | -89.0% | +16.4% | -75.9% | +46.7% | -158.1% | +42.9% |
| alltime | all time | -89.0% | +16.4% | -75.9% | +46.7% | -158.1% | +42.9% |
MiNK Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.99 M(+30.7%) | -$10.86 M(-10.1%) |
| Jun 2024 | - | -$2.29 M(-9.9%) | -$12.08 M(-13.3%) |
| Mar 2024 | - | -$2.54 M(-16.3%) | -$13.94 M(-11.6%) |
| Dec 2023 | -$15.76 M(-16.5%) | -$3.04 M(-27.9%) | -$15.76 M(-8.1%) |
| Sep 2023 | - | -$4.21 M(+1.4%) | -$17.16 M(-7.6%) |
| Jun 2023 | - | -$4.15 M(-4.9%) | -$18.56 M(-2.5%) |
| Mar 2023 | - | -$4.37 M(-1.4%) | -$19.04 M(+0.9%) |
| Dec 2022 | -$18.87 M | -$4.43 M(-21.1%) | -$18.87 M(+16.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$5.61 M(+21.4%) | -$16.14 M(+15.1%) |
| Jun 2022 | - | -$4.63 M(+10.2%) | -$14.02 M(+9.4%) |
| Mar 2022 | - | -$4.20 M(+146.5%) | -$12.81 M(-0.1%) |
| Dec 2021 | -$12.83 M(+53.8%) | -$1.70 M(-51.3%) | -$12.83 M(+15.3%) |
| Sep 2021 | - | -$3.50 M(+2.2%) | -$11.12 M(+45.8%) |
| Jun 2021 | - | -$3.42 M(-18.7%) | -$7.63 M(+81.3%) |
| Mar 2021 | - | -$4.21 M | -$4.21 M |
| Dec 2020 | -$8.34 M(-44.2%) | - | - |
| Dec 2019 | -$14.94 M | - | - |
FAQ
- What is MiNK Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for MiNK Therapeutics?
- What is MiNK Therapeutics annual CFO year-on-year change?
- What is MiNK Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for MiNK Therapeutics?
- What is MiNK Therapeutics quarterly CFO year-on-year change?
- What is MiNK Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for MiNK Therapeutics?
- What is MiNK Therapeutics TTM CFO year-on-year change?
What is MiNK Therapeutics annual cash flow from operations?
The current annual CFO of INKT is -$15.76 M
What is the all time high annual CFO for MiNK Therapeutics?
MiNK Therapeutics all-time high annual cash flow from operations is -$8.34 M
What is MiNK Therapeutics annual CFO year-on-year change?
Over the past year, INKT annual cash flow from operations has changed by +$3.10 M (+16.45%)
What is MiNK Therapeutics quarterly cash flow from operations?
The current quarterly CFO of INKT is -$2.99 M
What is the all time high quarterly CFO for MiNK Therapeutics?
MiNK Therapeutics all-time high quarterly cash flow from operations is -$1.70 M
What is MiNK Therapeutics quarterly CFO year-on-year change?
Over the past year, INKT quarterly cash flow from operations has changed by $0.00 (0.00%)
What is MiNK Therapeutics TTM cash flow from operations?
The current TTM CFO of INKT is -$10.86 M
What is the all time high TTM CFO for MiNK Therapeutics?
MiNK Therapeutics all-time high TTM cash flow from operations is -$4.21 M
What is MiNK Therapeutics TTM CFO year-on-year change?
Over the past year, INKT TTM cash flow from operations has changed by $0.00 (0.00%)